Dermatologists and subspecialty dermatopathologists,
|
|
- Darren Norman
- 5 years ago
- Views:
Transcription
1 Practical Strategies to Improve the Clinical Utility of the Dermatopathology Report Martin J. Trotter, MD, PhD, FRCPC; Sheila Au, MD, FRCPC; Karen A. Naert, MD, FRCPC Context. Dermatologists and subspecialty dermatopathologists, working together over many years, develop a common understanding of clinical information provided on the requisition and of terminology used in the pathology report. Challenges arise for pathologists without additional subspecialty training in dermatology/dermatopathology, and for any pathologist reporting skin biopsies for nondermatologists such as general practitioners or surgeons. Objective. To provide practical strategies to improve efficiency of dermatopathology sign-out, at the same time providing the clinician with clear diagnostic and prognostic information to guide patient management. Data Sources. The information outlined in this review Dermatologists and subspecialty dermatopathologists, working together over many years, develop a common language that marries the clinical information provided on the pathology requisition with the terminology used in the pathology report. Challenges arise for pathologists without additional subspecialty training in dermatology/dermatopathology, and for any pathologist reporting skin biopsies for nondermatologists such as general practitioners or surgeons. This review is targeted at general surgical pathologists who are reporting skin biopsies. The objective is to provide practical strategies to improve efficiency of dermatopathology sign-out, while providing the clinician with clear diagnostic and prognostic information to guide patient management. Strategies such as including pertinent negatives in a report and using generic diagnoses where is based on our own experiences with routine dermatopathology and dermatology practice, and review of Englishlanguage articles related to the selected topics discussed. Conclusions. Using generic diagnoses for some benign lesions, listing pertinent negatives in the pathology report, and using logical risk management strategies when reporting on basal cell carcinoma, partial biopsies, or specimens with incomplete clinical information allow the pathologist to convey relevant and useful diagnostic information to the treating clinician. (Arch Pathol Lab Med. 2016;140: ; doi: / arpa ra) appropriate are discussed. Apart from interpretative and diagnostic challenges, many pathologists face difficulties interpreting the limited clinical information that is often provided on the requisition. Communication failures between clinicians and pathologists have implications for pathologist efficiency as well as the quality and safety of patient care. 1 Pathology reporting in the absence of complete clinical information or diagnosis of partial biopsy specimens is a significant risk to the patient and to the signout pathologist. We will discuss strategies to reduce this risk and communicate useful information to the treating clinician. The topics chosen reflect the authors experience based on intradepartmental consultation with general surgical pathology colleagues faced with challenges in dermatopathology reporting. Accepted for publication April 5, From the Department of Pathology and Laboratory Medicine (Dr Trotter) and the Division of Dermatology, Department of Medicine (Dr Au), Providence Health Care, Vancouver, British Columbia, Canada; the Departments of Pathology and Laboratory Medicine (Dr Trotter) and Dermatology and Skin Science (Dr Au), University of British Columbia, Vancouver, British Columbia, Canada; and the Department of Pathology and Laboratory Medicine, University of Calgary, Calgary Laboratory Services, Calgary, Alberta, Canada (Dr Naert). The authors have no relevant financial interest in the products or companies described in this article. Portions of this article were presented at the Canadian Anatomic and Molecular Pathology Conference; January 30, 2016; Whistler, British Columbia, Canada. Reprints: Martin J. Trotter, MD, PhD, FRCPC, Department of Pathology and Laboratory Medicine, Providence Health Care, St. Paul s Hospital, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada ( mtrotter@providencehealth.bc.ca). IMPROVING EFFICIENCY USEFUL GENERIC DIAGNOSES While clearly there are many, many important diagnoses rendered by a pathologist reporting skin biopsies, there are also a large proportion of specimens in which a definitive pathologic diagnosis is often not possible, but the likelihood of missing a malignant or clinically important lesion is remote. 2 For such cases, accuracy/precision is relatively less important in terms of patient prognosis and care. It is very useful for the pathologist to have an armamentarium of generic diagnosis she/he can use to sign out such cases expediently in a clinically useful manner. Benign Keratoses Classic patterns of seborrheic keratosis are easily diagnosed but many benign keratotic epidermal lesions seem to defy precise classification. For example, is the lesion a Arch Pathol Lab Med Vol 140, August 2016 Dermatopathology Reporting Trotter et al 759
2 seborrheic keratosis or a wart (Figure 1, A)? When such benign lesions are difficult to classify, the terms benign keratosis or verrucous keratosis can be very helpful (sometimes with inclusion of the pertinent negatives [see below]). For lesions that are not clinically keratotic, the term squamous papilloma can sometimes be used, especially at certain anatomic sites such as the eyelid where there is often considerable overlap between seborrheic keratosis and a simple skin tag. Keratotic lesions that are flat histologically, with minimal epidermal thickening and no downward budding, can usefully be signed out as seborrheic keratosis, flat type, solar lentigo, flat type (usually on sun-damaged skin of head and neck), 3 or large cell acanthoma if the lesional keratinocytes are clearly markedly increased in size (Figure 1, B). 4 Lichenoid keratosis is a very common diagnosis with lesions most often occurring on the trunk and proximal upper limbs of middle-aged or older patients. 5 The lesion represents a lichenoid reaction to a solar lentigo or seborrheic keratosis. The clinical impression is often that of superficial basal cell carcinoma. Unless we are given a clear clinical history suggesting a lichenoid rash, then such a solitary lesion is almost always benign lichenoid keratosis (Figure 1, C). In our experience, this lesion often presents problems in classification for the nondermatopathologist. Finally, endophytic-pattern benign keratoses and similar benign squamoproliferative lesions can sometimes defy precise classification and often overlap in their histologic features. Within this category, diagnoses may include irritated seborrheic keratosis, 6 inverted follicular keratosis, 7 and endophytic pattern verruca vulgaris. When uncertain, benign endophytic squamoproliferative lesion, negative for atypia can usefully be used as a generic benign diagnosis for such lesions (Figure 1, D). Lentiginous Melanocytic Nevus Heavily pigmented melanocytic nevi are often biopsied. The pathology may show a lentiginous pattern nevus, sometimes purely junctional, associated with increased melanin pigmentation, sometimes with pigment transfer into overlying stratum corneum ( pigmented parakeratosis ) and melanophages in the dermis. Inexperienced pathologists sometimes confuse the histology of these nevi (also known as hypermelanotic nevi) 8 with an atypical or dysplastic pattern. Importantly, such nevi are not limited to young patients and are frequently seen in older individuals. 9 Lentiginous melanocytic nevus (Figure 2, A through D) is a useful diagnosis to have in our repertoire. This pattern of nevus is easily recognized pathologically and indeed is often a low-power diagnosis with a brief examination at higher magnification to exclude marked melanocytic atypia or other worrisome features. Eczematous Dermatitis Dermatologists rarely biopsy an eczematous lesion to differentiate between clinical variants of spongiotic dermatitis, so it is sufficient for the pathologist to recognize epidermal spongiosis and to classify the inflammatory reaction pattern as spongiotic. Subtle clues, such as superficial dyskeratotic keratinocytes in contact dermatitis can be used, but in most circumstances, the diagnosis spongiotic dermatitis is sufficient information for the clinician to manage the patient. For the dermatologist, a more usual situation occurs when a papulosquamous condition looks like dermatitis but may have atypical clinical features, thus expanding the differential diagnosis to include conditions such as psoriasis, subacute cutaneous lupus, pityriasis rosea, dermatophyte infection, or mycosis fungoides. When the pathologic process shows spongiotic dermatitis but the clinical differential diagnosis is broader, then the addition of pertinent negatives to the pathology report is very useful to the dermatologist (see below). For example: spongiotic dermatitis, fungal stain negative, spongiotic dermatitis, with features consistent with pityriasis rosea, or spongiotic dermatitis, negative for lymphocyte atypia or epidermotropism. JUST SAY NO : LISTING THE PERTINENT NEGATIVES Including pertinent negatives in the diagnosis, microscopic description, or comment section of our pathology report is very useful. Absence of certain findings can eliminate broad categories within the clinical differential diagnosis and increase clinician confidence in the pathologist s interpretation. Specifically excluding clinically suggested diagnoses (eg, there are no histopathologic features of lupus erythematosus, basal cell carcinoma is not present, there is no evidence of granulomatous inflammation ) directly answers the clinician s queried diagnoses noted on the requisition. Pertinent negatives included in the report should be relevant to the clinical information provided. Even when the histopathology correlates well with the clinical impression, a short listing of relevant negative findings within the microscopic description or comment section is often appreciated by the submitting dermatologist, providing assurance that the slides have been carefully reviewed, and increasing their confidence in our report. Benign Melanocytic Lesions When a clinician biopsies or removes a clinically suspicious pigmented lesion, but the pathologic process shows an entirely benign pattern, then pertinent negative findings may be helpful in assuring the clinician that the pathologist reviewed the slides carefully and was aware of the clinical atypia. No evidence of architectural or cytologic atypia, no evidence of pagetoid spread, or mitotic figures not seen can all be useful phrases. For example, if the clinical diagnosis is melanoma in situ, but the pathologic diagnosis is benign compound melanocytic nevus, then the report might include phraseology such as poorly demarcated lesion with mild architectural atypia only. No evidence of pagetoid spread or other features to suggest melanoma in situ. Epidermal Lesions Pathology reports on epidermal tumors thought clinically to be either malignant (squamous cell carcinoma) or virally induced (condyloma acuminatum), but showing benign, noninvasive lesions, or nonspecific changes on biopsy, can also benefit from inclusion of pertinent negatives, such as negative for atypia/dysplasia, full-thickness atypia, invasion, or viral cytopathic effect. For example, if the clinical impression is condyloma acuminatum but the biopsy is not diagnostic, then benign squamous papilloma; no definite human papillomavirus effect; no epidermal atypia can reassure the clinician that the clinical diagnosis has been considered and that diagnostic features are not present histologically. 760 Arch Pathol Lab Med Vol 140, August 2016 Dermatopathology Reporting Trotter et al
3 Figure 1. Useful generic diagnoses for keratotic lesions. A, Verrucous keratosis. B, Large cell acanthoma. C, Lichenoid keratosis. D, Irritated seborrheic keratosis (hematoxylin-eosin, original magnifications 320 [A, C, and D] and 3100 [B]). Nonneoplastic/Inflammatory Conditions Incorporation of negative findings into the pathology report may effectively exclude one or more of a clinician s differential diagnoses for a skin eruption or nonneoplastic condition. For example, if there is no lichenoid inflammation present histologically, the diagnosis is not lichen planus; absence of granulomata excludes sarcoidosis; lack of dermal mucin rules out a mucinosis. When certain inflammatory cells are absent, this should also be mentioned when relevant. For example, if the clinical diagnosis is insect bite reaction, urticaria, or bullous pemphigoid, the absence of eosinophils in the biopsy specimen should specifically be noted. The presence or absence of eosinophils can also be helpful in distinguishing a psoriasiform spongiotic reaction (often present) from psoriasis (absent), or a lichenoid drug reaction (present) (Figure 3, A and B) from lupus erythematosus (absent). Similarly for neutrophils in cases of suspected Sweet syndrome or other neutrophilic dermatosis and mast cells in cases of suspected urticaria pigmentosa. An example diagnosis for a patient suspected of having a lichenoid drug reaction might read Nonspecific spongiotic dermatitis. No evidence of a lichenoid reaction. Eosinophils not present. Fungal stain negative. DEALING WITH INSUFFICIENT CLINICAL INFORMATION Clinical information provided on the skin biopsy requisition is often lacking or suboptimal. 1,10 Missing clinical information results in pathologist inefficiency, uncertainty in diagnosis, and physician stress. In a recent study, 1 91% of dermatopathologists moderately or strongly agreed that vague clinical impressions or missing relevant clinical information makes them uneasy. Forty-four percent of respondents in this survey spent 30 minutes or more daily searching for relevant clinical information to assist histopathologic interpretation. Possible strategies to address lack of relevant clinical information are shown in the Table. Useful Terminology When no clinical information is provided (eg, requisition simply states skin biopsy or lesion ), it is our practice to include a disclaimer in the diagnostic line, regardless of whether the biopsy is diagnostic or not. For example, when no clinical information is provided, and the pathologic process shows benign nevus, the diagnosis might read intradermal melanocytic nevus (no clinical information provided). In such cases, it is usually highly inefficient to spend time contacting the clinician for more information. Arch Pathol Lab Med Vol 140, August 2016 Dermatopathology Reporting Trotter et al 761
4 Figure 2. Lentiginous (hypermelanotic) melanocytic nevus. A, Downgrowth of rete ridges, small junctional nests, heavily pigmented epidermis, and melanophages. B, Variably sized small junctional nests with underlying melanophages. C, Melanin transfer into the stratum corneum (pigmented parakeratosis). D, Dysplastic junctional melanocytic nevus showing architectural atypia with bridging of irregular junctional nests (hematoxylin-eosin, original magnifications 320 [A, B, and D] and 3100 [C]). Figure 3. Importance of eosinophils in inflammatory dermatoses. A, Low power of interface dermatitis consistent with lichen planus. B, Numerous eosinophils (arrows) in the inflammatory infiltrate suggest the differential diagnosis of lichenoid drug eruption (hematoxylin-eosin, original magnifications 320 [A] and 100 [B]). 762 Arch Pathol Lab Med Vol 140, August 2016 Dermatopathology Reporting Trotter et al
5 Possible Strategies to Address Lack of Relevant Clinical Information Strategy Specimen rejection at accessioning Pursuit of more clinical information Phone clinician Text/ clinician Request fax or scan of paper charts Access to medical record Use disclaimer terminology at signout to highlight potential limitations because of limited clinical information Potential Outcomes Highly inefficient Specimen still returned with minimal information Difficult to access Multiple calls often required Higher response rate Confidentiality/privacy issues Access to clinician notes Often restricted to laboratory information system Very helpful for inpatients if pathologist has access to PCIS Poor patient management Medicolegal risk Often the last resort Abbreviation: PCIS, patient care information system. The exception would be for partial biopsies or incomplete excisions (see below). When the pathologic interpretation is less clear, and no further clinical information can be obtained from the patient s physician, then generic phraseology is used (eg, lichenoid reaction; see comment). Within the comment section the inadequate or incomplete clinical information should be noted and any attempts to retrieve further clinical information, documented (eg, there is no record of a previous biopsy in our laboratory information system ; or voic left for Dr X at 1630 hours, May 6, 2015 addendum will be issued if further clinical information received ). Surprisingly, a recent study of reasons for addendum reports in surgical pathology does not list receipt of further clinical information as reason for an addendum to be issued. 11 THE INSUFFICIENT OR PARTIAL BIOPSY Not infrequently, the pathologist signing out skin biopsies will encounter specimens that have sampled only part of the lesion. This problem arises most commonly with superficial shave biopsies, which may lack even full-thickness epidermis, and with punch biopsies, where the lateral edges of the lesion often remain unsampled. Clearly, interpretation of these specimens risks misdiagnosis if the most salient histopathologic features are not present within the biopsy material. Melanocytic Lesions The odds of histopathologic misdiagnosis increases when assessing shave and punch biopsies of melanocytic lesions, as opposed to excisional biopsies. 12 This risk is highest for partially sampled, broad asymmetric melanocytic lesions, where diagnostic features of melanoma may be missed adjacent to what otherwise appears to be an atypical or dysplastic nevus. The latter point is highlighted by High s admonition to beware of a partial biopsy in his article on malpractice in dermatopathology. 13 It is essential that we use terminology that explicitly states both the partial nature of the biopsy and the diagnostic uncertainty because of the biopsy limitations (Figure 4, A through D). The terminology selected should reflect the level of concern held by the pathologist about a given lesion. For example, for a benign compound nevus or a mildly atypical nevus that has been partially transected by the biopsy and for which the risk to the patient is felt to be remote, a simple note appended to the diagnosis may suffice. For example: Compound melanocytic nevus with mild atypia (partial biopsy) (Figure 4, C). For more worrisome melanocytic lesions about which there is considerable concern, a comment similar to the following may be useful: This atypical compound melanocytic proliferation involves both peripheral biopsy edges, and the findings may not be representative of the lesion as a whole. Further recommendations including to rebiopsy any residual or recurrent lesion at the site, or conservative reexcision recommended should be provided. High 13 also advises that pathologists should provide guidance to the clinician by suggesting biopsy techniques that are most likely to render the most accurate information (eg, recommending deep saucerization or conservative excision rather than shave biopsy). An additional problem encountered concerns partial biopsies of melanocytic lesions for which the size of the lesion could significantly influence the pathologist s concern about it. For example, broad lesions on acral skin are a source of greater concern than small, symmetric ones. Therefore, a partial biopsy of an acral melanocytic lesion for which a size of 3 mm has been provided by the clinician would be less concerning than one for which a size of 10 mm has been provided. In our opinion, the clinical size of a melanocytic lesion, especially if the biopsy is a partial sample, is essential clinical information that must be provided by the submitting physician. The absence of lesion size information should prompt a comment that The size of the lesion has not been provided. Partial biopsies of melanocytic lesions may not be representative of the lesion as a whole. Epidermal Lesions A very common problem in dermatopathology is the superficial biopsy of squamous proliferations. The superficial epidermal changes of many lesions can overlap; for example, the top of a basal cell carcinoma, an actinic keratosis, and an invasive squamous cell carcinoma, can all appear identical if only the superficial layers of the epidermis are examined. Unfortunately, a definitive diagnosis may not be possible on specimens that are suboptimal/inadequate owing to biopsy technique (Figure 4, A and B). 14 It is prudent to consider additional levels in an attempt to identify diagnostic features in these biopsies. 15 However, if only superficial epidermis persists despite level sections, it is necessary to resort to descriptive diagnoses. If the biopsy has sampled only the top of a squamous lesion, options for the diagnostic line include surface of an atypical squamous proliferation or dysplastic squamous lesion, transected at the base, with an additional comment that a definitive diagnosis is not possible owing to the superficial biopsy. Some superficial biopsies of dysplastic squamous lesions would lend themselves to a diagnosis of at least actinic keratosis, transected at the base, invasive squamous cell carcinoma cannot be excluded. These diagnoses provide Arch Pathol Lab Med Vol 140, August 2016 Dermatopathology Reporting Trotter et al 763
6 Figure 4. Partial biopsies requiring caution in pathology sign-out. A, Partial sampling of an acral actinic keratosis, but invasive carcinoma cannot be excluded. B, Surface of a very keratotic squamoproliferative lesion, with minimal epidermis for evaluation. C, Superficial shave specimen of a junctional melanocytic proliferation, with no clinical description or lesion size provided. D, Superficial biopsy to rule out basal cell carcinoma or sebaceous hyperplasia; no lesion sampled, biopsy likely too superficial (hematoxylin-eosin, original magnifications 320 [A through C] and 340 [D]). the clinicians with the information that the lesion appears to be squamous, that there is the possibility of a deeper lesion including invasive carcinoma that has not been sampled, and leaves them the option to rebiopsy or follow up the patient according to their degree of clinical suspicion about the lesion. In all such cases, an attempt to make a diagnosis is appropriate, but we should not feel obligated to stretch ourselves to render a possibly incorrect diagnosis on an inadequate specimen. A descriptive diagnosis with a comment describing the biopsy limitations is appropriate. REPORTING MARGINS FOR BASAL CELL CARCINOMA Biopsies and excisions of basal cell carcinomas are among the most common dermatopathology specimens received. It has been repeatedly established that recurrences of basal cell carcinoma occur even when margins of the original biopsy are reported as negative; in contrast, many reexcisions of margin-positive basal cell carcinomas contain no residual tumor. 16,17 Given this, one must exercise caution when interpreting and reporting margins on basal cell carcinoma. The recurrence of carcinoma in patients who had negative margins on the original procedure has been attributed to the bread-loafing technique used in grossing surgical pathology specimens, wherein the entire circumferential margin is not visualized and there is the potential to miss a focally positive margin. 18,19 In light of this, in excision specimens in which the visualized margin appears negative, it would be prudent to report this as margins clear in the planes of examined sections, which conveys to the clinician that the entire circumferential margin has not been examined. Another possible source of missed positive margins occurs when the epithelial component of basal cell carcinoma is free of the margins, but the stromal reaction around the tumor extends to the margin (Figure 5, A and B). This is particularly a problem in superficial pattern basal cell carcinomas, which often show discontinuity in a given lesion, rather than a tumor with well-defined margins. According to LeBoit, 20 stromal changes at the margin of a basal cell carcinoma most likely indicate that there is residual tumor beyond that margin. Likewise, a scar at the margin should be an indication that residual tumor may be left in the patient. 764 Arch Pathol Lab Med Vol 140, August 2016 Dermatopathology Reporting Trotter et al
7 Figure 5. Stromal reactions adjacent to basal cell carcinoma (BCC) can make margin assessment difficult. A, Superficial pattern BCC: intervals between carcinoma nests are similar to the distance from nearest margin. B, Tumor stromal reaction at a painted margin (hematoxylin-eosin, original magnifications 320 [A] and 340 [B]). Basal cell carcinoma may be seen in the triangular specimen tips of a bread-loafed elliptical excision. Two options are available: (1) examine multiple deeper sections through the tissue block, or (2) consider the tip margins negative if the tumor is not present at the painted surgical resection margins. We favor option 2 because unless the entire ellipse is serially sectioned, it makes little sense to examine multiple deeper levels from the specimen tips. In summary, the surgical pathologist should report margins on basal cell carcinoma with appropriate comment or warning regarding the possibility of a missed positive margin due to sampling error. If peritumoral stroma is seen at a margin, this should be reported with inclusion of a comment that stromal reaction at a margin is suspicious for an incompletely excised lesion. Finally, given various treatment measures used for basal cell carcinoma, both surgical and medical, it is advisable to report margins on this tumor, but recommendations regarding reexcision should be avoided, unless requested by the clinician. 21 CONCLUSIONS Using generic diagnoses for some benign lesions, listing pertinent negatives in the pathology report, and using logical risk management strategies when reporting on basal cell carcinoma, partial biopsies, or specimens with incomplete clinical information allow the pathologist to convey relevant and useful diagnostic information to the treating clinician and to sign out skin specimens in an efficient manner. References 1. Comfere NI, Peters MS, Jenkins S, Lackore K, Yost K, Tilburt J. Dermatopathologists concerns and challenges with clinical information in the skin biopsy requisition form: a mixed-methods study. J Cutan Pathol. 2015;42(5): Eads TJ, Chuang TY, Fabré VC, Farmer ER, Hood AF. The utility of submitting fibroepithelial polyps for histological examination. Arch Dermatol. 1996;132(12): Andersen WK, Labadie RR, Bhawan J. Histopathology of solar lentigines of the face: a quantitative study. J Am Acad Dermatol. 1997;36(3, pt 1): Fraga GR, Amin SM. Large cell acanthoma: a variant of solar lentigo with cellular hypertrophy. J Cutan Pathol. 2014;41(9): Jang KA, Kim SH, Choi JH, Sung KJ, Moon KC, Koh JK. Lichenoid keratosis: a clinicopathologic study of 17 patients. J Am Acad Dermatol. 2000;43(3): Lever WF. Inverted follicular keratosis is an irritated seborrheic keratosis. Am J Dermatopathol. 1983;5(5): Mehregan AH. Inverted follicular keratosis is a distinct follicular tumor. Am J Dermatopathol. 1983;5(5): Cohen LM, Bennion SD, Johnson TW, Golitz LE. Hypermelanotic nevus: clinical, histopathologic, and ultrastructural features in 316 cases. Am J Dermatopathol. 1997;19(1): Martinka M, Bruecks AK, Trotter MJ. Histologic spectrum of melanocytic nevi removed from patients.60 years of age. J Cutan Med Surg. 2007;11(5): Wong C, Peters M, Tilburt J, Comfere N. Dermatopathologists opinions about the quality of clinical information in the skin biopsy requisition form and the skin biopsy care process: a semiqualitative assessment. Am J Clin Pathol. 2015;143(4): Babwah JP, Khalifa M, Rowsell C. Analysis of addenda in anatomic pathology as a quality monitoring initiative. Arch Pathol Lab Med. 2014;138(11): Ng JC, Swain S, Dowling JP, Wolfe R, Simpson P, Kelly JW. The impact of partial biopsy on histopathologic diagnosis of cutaneous melanoma. Arch Dermatol. 2010;146(3): High WA. Malpractice in dermatopathology principles, risk mitigation, and opportunities for improved care for the histologic diagnosis of melanoma and pigmented lesions. Clin Lab Med. 2008;28(2): Sellheyer K, Nelson P, Bergfeld WF. Nonspecific histopathological diagnoses: the impact of partial biopsy and the need for a consensus guideline. JAMA Dermatol. 2014;150(1): Bruecks AK, Shupe JM, Trotter MJ. Prospective step sections for small skin biopsies. Arch Pathol Lab Med. 2007;131(1): Nagore E, Grau C, Molinero J, Fortea JM. Positive margins in basal cell carcinoma: relationship to clinical features and recurrence risk: a retrospective study of 248 patients. J Eur Acad Dermatol Venereol. 2003;17(2): Jackson JE, Kelly B, Petitt M, Uchida T, Wagner RF Jr. Predictive value of margins in diagnostic biopsies of nonmelanoma skin cancers. J Am Acad Dermatol. 2012;67(1): Rapini RP. Comparison of methods for checking surgical margins. JAm Acad Dermatol. 1990;23(2, pt 1): Kimyai-Asadi A, Goldberg LH, Jih MH. Accuracy of serial transverse crosssections in detecting residual basal cell carcinoma at the surgical margins of an elliptical excision specimen. J Am Acad Dermatol. 2005;53(3): LeBoit PE. Stroma, interrupted. Am J Dermatopathol. 2001;23(1): Weinstein MC, Brodell RT, Bordeaux J, Honda K. The art and science of surgical margins for the dermatopathologist. Am J Dermatopathol. 2012;34(7): Arch Pathol Lab Med Vol 140, August 2016 Dermatopathology Reporting Trotter et al 765
Important Decisions in Dermatopathology: The Clinico- Pathologic Correlation. Dermatopathology Specialists Needed. Changing Trends
Important Decisions in Dermatopathology: The Clinico- Pathologic Correlation Uma Sundram, MD, PhD Departments of Pathology and Dermatology Stanford University May 29, 2008 Dermatopathology Specialists
More informationBenign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more
Benign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more common on the trunk; but extremities, head and neck are
More informationBasal cell carcinoma 5/28/2011
Goal of this Presentation A practical approach to the diagnosis of cutaneous carcinomas and their mimics Thaddeus Mully, MD University of California San Francisco To review common non-melanoma skin cancers
More informationDavid B. Troxel, MD. Common Medicolegal Situations: Misdiagnosis of Melanoma
Common Medicolegal Situations: Misdiagnosis of Melanoma David B. Troxel, MD Medical Director, The Doctors Company, Napa, California Clinical Professor Emeritus, University of California at Berkeley Past
More informationHistopathology: skin pathology
Histopathology: skin pathology These presentations are to help you identify, and to test yourself on identifying, basic histopathological features. They do not contain the additional factual information
More informationA PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL
A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL OBJECTIVES Discuss current trends and changing concepts in our understanding of
More informationLichenoid Tissue Reaction in Malignant Melanoma A Potential Diagnostic Pitfall
natomic Pathology / LICHENOID TISSUE RECTION IN MLIGNNT MELNOM Lichenoid Tissue Reaction in Malignant Melanoma Potential Diagnostic Pitfall CPT Scott R. Dalton, MC, US, 1,3 Capt Matt. aptista, USF, MC,
More informationMECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB. Friday, February 12, :30 am 11:00 am
MECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB Friday, February 12, 2012 9:30 am 11:00 am FACULTY COPY GOALS: Describe the basic clinical and morphologic features of various
More informationAssociate Clinical Professor of Dermatology MUSC
Re-excision of Moderately Dysplastic Nevi: Should we or shouldn t we? John C. Maize, Jr, M.D. Dermatologist and Dermatopathologist Trident Dermatology, Charleston SC Associate Clinical Professor of Dermatology
More informationISPUB.COM. Seborrheic Keratosis: A Pictorial Review of the Histopathologic Variations. D Sarma, S Repertinger
ISPUB.COM The Internet Journal of Dermatology Volume 7 Number 2 Seborrheic Keratosis: A Pictorial Review of the Histopathologic Variations D Sarma, S Repertinger Citation D Sarma, S Repertinger.. The Internet
More informationPathology of the skin. 2nd Department of Pathology, Semmelweis University
Pathology of the skin 2nd Department of Pathology, Semmelweis University Histology of the skin Epidermis: Stratum corneum Stratum granulosum Stratum spinosum Stratum basale Dermis: papillary and reticular
More informationMECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB. Friday, February 13, :30 am 11:00 am
MECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB Friday, February 13, 2009 9:30 am 11:00 am FACULTY COPY GOALS: Describe the basic clinical and morphologic features of various
More informationActinic keratosis (AK): Dr Sarma s simple guide
Actinic keratosis (AK): Dr Sarma s simple guide Actinic keratosis is a very common lesion that you will see in your day-to-day practice. First, let me explain the name Actinic keratosis. It means keratosis
More informationHistopathology of Melanoma
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 48, 409-416 (1975) Histopathology of Melanoma G. J. WALKER SMITH Department ofpathology, Yale University School ofmedicine, 333 Cedar Street, New Haven, Connecticut
More informationDESCRIPTIONS FOR MED 3 ROTATIONS Dermatology A3S
Regardless of your future field of practice, you will be exposed to a considerable amount of dermatology and this rotation provides you the chance to see a range of skin diseases. You will have the opportunity
More informationSTUDY. Differences in Biopsy Techniques of Actinic Keratoses by Plastic Surgeons and Dermatologists. the most common reasons
STUDY Differences in Biopsy Techniques of Actinic Keratoses by Plastic Surgeons and Dermatologists A Histologically Controlled Pilot Study Klaus Sellheyer, MD; Wilma F. Bergfeld, MD Objective: To compare
More informationBenign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc
1 Benign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc Benign lesions Seborrheic Keratoses: Warty, stuck-on Genetics and birthdays Can start in late
More informationIdentifying Skin Cancer. Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018
Identifying Skin Cancer Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018 American Cancer Society web site Skin Cancer Melanoma Non-Melanoma
More informationChapter 6 Squamous Cell Carcinoma: Variants and Challenges
Chapter 6 Squamous Cell Carcinoma: Variants and Challenges Michael B. Morgan EPIDEMIOLOGY: Second most common skin cancer, rare in the dark-skinned races. ETIOLOGY: Ultraviolet light, HPV infection. PATHOGENESIS:
More informationDermatopathology: The tumor is composed of keratinocytes which show atypia, increase mitoses and abnormal mitoses.
Squamous cell carcinoma (SCC): A common malignant tumor of keratinocytes arising in the epidermis, usually from a precancerous condition: 1- UV induced actinic keratosis, usually of low grade malignancy.
More informationDermatopathology. Dr. Rafael Botella Estrada. Hospital La Fe de Valencia
Dermatopathology Dr. Rafael Botella Estrada. Hospital La Fe de Valencia Melanoma and mimics Dr. Martin Mihm Malignant lesions result from the accumulation of mutations Class I lesions (benign) Class II
More informationSimulators of melanoma
Simulators of melanoma Philip E. LeBoit, M.D. Depts. of Pathology and Dermatology University of California, San Francisco Simulators of melanoma Simulators of melanoma in situ Melanocytic Non-melanocytic
More informationMalignant tumors of melanocytes : Part 3. Deba P Sarma, MD., Omaha
Malignant tumors of melanocytes : Part 3 Deba P Sarma, MD., Omaha Let s go over one case of melanoma using the following worksheet. Of the various essential information that needs to be included in the
More informationHow to decipher a pathology report for alopecia
How to decipher a pathology report for alopecia DISCLOSURE OF RELATIONSHIPS WITH INDUSTRY Lynne J. Goldberg, MD S063-Hair Disorders Made Easier DISCLOSURES I do not have any relationships with industry
More informationDermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial
Dermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial Cutaneous Oncology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI
More informationPathology of the skin. Dr Fónyad László, 1sz. Patológiai és Kísérleti Rákkutató Intézet, SE
Pathology of the skin Dr Fónyad László, 1sz. Patológiai és Kísérleti Rákkutató Intézet, SE The skin Biggest organ Kb. 1.8 nm Kb. 10 kg Most frequent site for tumor development (BCC) Pathology of the skin
More informationIT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY
IT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY Skin, Bones, and other Private Parts Symposium Dermatology Lectures by Debra Shelby, PhD, DNP, FNP-BC, FADNP, FAANP Debra Shelby,
More informationMelanoma-Back to Basics I Thought I Knew Ya! Paul K. Shitabata, M.D. Dermatopathologist APMG
Melanoma-Back to Basics I Thought I Knew Ya! Paul K. Shitabata, M.D. Dermatopathologist APMG At tumor board, a surgeon insists that all level II melanomas are invasive since they have broken through the
More informationEARLY ONLINE RELEASE
EARLY ONLINE RELEASE Note: This article was posted on the Archives Web site as an Early Online Release. Early Online Release articles have been peer reviewed, copyedited, and reviewed by the authors. Additional
More informationDiagnosis of Lentigo Maligna Melanoma. Steven Q. Wang, M.D. Memorial Sloan-Kettering Cancer Center Basking Ridge, NJ
Diagnosis of Lentigo Maligna Melanoma Steven Q. Wang, M.D. Memorial Sloan-Kettering Cancer Center Basking Ridge, NJ Conflict of Interest: None Topics Epidemiology and Natural History Clinical and Histologic
More informationTips on getting the most from your alopecia pathology reports. D irector, H a ir C linic, Boston Medical C e n ter
Tips on getting the most from your alopecia pathology reports Lynne J. Goldberg, MD J a g Bhawan Professor o f Dermatology a n d Pathology & Laboratory Medicine Boston U n iversity School of Medicine D
More informationCASE REPORT Superficial Spreading Basal Cell Carcinoma of the Face: A Surgical Challenge
CASE REPORT Superficial Spreading Basal Cell Carcinoma of the Face: A Surgical Challenge Yuri T. Jadotte, MD, a Navér A. Sarkissian, MD, PhD, b,c Helchem Kadire, MD, c and W. Clark Lambert, MD, PhD b,c
More informationCancer Reporting for Dermatologists. Florida Department of Health Florida Cancer Data System. March 9, Agenda
Cancer Reporting for Dermatologists Florida Department of Health Florida Cancer Data System March 9, 2011 Agenda Welcome Introductions Cancer Reporting in Florida BETA Participation Expectations Review
More informationMalignant tumors of melanocytes: Part 1. Deba P Sarma, MD., Omaha
Malignant tumors of melanocytes: Part 1 Deba P Sarma, MD., Omaha The melanocytic tumor is one of the most difficult and confusing areas in Dematopathology. It is true that most (95%) of such lesions are
More information04/09/2018. Squamous Cell Neoplasia and Precursor Lesions. Agenda. Squamous Dysplasia. Squamo-proliferative lesions. Architectural features
Squamous Cell Neoplasia and Precursor Lesions Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology Chair of Pathology and Laboratory Medicine University of Arkansas for Medical
More informationCitation The Journal of Dermatology, 37(8), available at
NAOSITE: Nagasaki University's Ac Title Two cases of blaschkitis with promi Author(s) Utani, Atsushi Citation The Journal of Dermatology, 37(8), Issue Date 2010-08 URL Right http://hdl.handle.net/10069/25634
More informationAmong the benign intraepithelial melanocytic proliferations, Inflamed Conjunctival Nevi. Histopathological Criteria. Resident Short Reviews
Resident Short Reviews Inflamed conjunctival nevi (ICN) may suggest malignancy because of their rapid growth and atypical histology. The objective of this study was to characterize the diagnostic features
More informationHistotechnological problems in dermatopathology and their possible consequences
Histotechnological problems in dermatopathology and their possible consequences Zsolt B. Argenyi, M.D. Professor of Pathology & Dermatology Director of Dermatopathology University of Washington, Seattle,
More informationالمركب النموذج--- سبيتز وحمة = Type Spitz's Nevus, Compound SPITZ NEVUS 1 / 7
SPITZ NEVUS 1 / 7 Epidemiology An annual incidence rate of 1.4 cases of Spitz nevus per 100,000 individuals has been estimated in Australia, compared with 25.4 per 100,000 individuals for cutaneous melanoma
More informationNEOPLASMS OF THE SURFACE EPITHELIUM (KERATINOCYTES)
NEOPLASMS OF THE SURFACE EPITHELIUM (KERATINOCYTES) Papillary Lesions Precancerous Lesions Keratinocyte Proliferations Carcinomas Melanotic Lesions Melanomas Normal Mucosa Keratin layer Spinous layer Basal
More informationDesmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC
R/O BCC Sabine Kohler, M.D. Professor of Pathology and Dermatology Dermatopathology Service Stanford University School of Medicine Clinical Information 74 y.o. man with lesion on left side of neck r/o
More informationManagement of Atypical Pigmented Lesions
Management of Atypical Pigmented Lesions Jennifer A. Stein MD, PhD Associate Director, Pigmented Lesion Section Ronald O. Perelman Department of Dermatology NYU Langone Medical Center July 29, 2017 1-4
More informationMelanoma and Dermoscopy. Disclosure Statement: ABCDE's of melanoma. Co-President, Usatine Media
Melanoma and Dermoscopy Richard P. Usatine, MD, FAAFP Professor, Family and Community Medicine Professor, Dermatology and Cutaneous Surgery Medical Director, University Skin Clinic University of Texas
More informationBenign Lichenoid Keratosis
Benign Lichenoid Keratosis ALAN F. FRIGY, M.D. AND PHILIP H. COOPER, M.D. The microscopic spectrum of benign lichenoid keratosis (BLK) was studied by examination of 30 examples. BLK consists of a segment
More informationCommon Benign Lesions and Skin Cancers. 22nd May 2015 Dr Mark Foley
Common Benign Lesions and Skin Cancers 22nd May 2015 Dr Mark Foley Thank you for downloading this file. This intended to supplement the presentation given at the NZ Wound Care Conference, it is not intended
More informationMelanocytes in nonlesional sun-exposed skin: A multicenter comparative study
Melanocytes in nonlesional sun-exposed skin: A multicenter comparative study AliHendi,MD, a,b David A. Wada, MD, d M. Amanda Jacobs, MD, e JuliaE.Crook,PhD, c Kimberly R. Kortuem, MD, d Brent R. Weed,
More informationCME/SAM. Measures of Completeness and Accuracy of Clinical Information in Skin Biopsy Requisition Forms An Analysis of 249 Cases
Measures of Completeness and Accuracy of Clinical Information in Skin Biopsy Requisition Forms An Analysis of 249 Cases Ryan C. Romano, DO, 1 Paul J. Novotny, MS, 2 Jeff A. Sloan, PhD, 2 and Nneka I. Comfere,
More informationDermoscopy: Recognizing Top Five Common In- Office Diagnoses
Dermoscopy: Recognizing Top Five Common In- Office Diagnoses Vu A. Ngo, DO Department of Family Medicine and Dermatology Choctaw Nation Health Services Authority Learning Objectives Introduction to dermoscopy
More informationLENTIGO SIMPLEX. Epidemiology
LENTIGO SIMPLEX Epidemiology The frequency of lentigo simplex in children and adults has not been determined. There does not appear to be a racial or gender predilection. Lentigo simplex is the most common
More informationSkin Cut Up D R R O K I A H A L I C O N S U L T A N T D E R M A T O P A T H O L O G I S T S T H
Skin Cut Up D R R O K I A H A L I C O N S U L T A N T D E R M A T O P A T H O L O G I S T S T H General Instructions 5.1.1 The type of biopsy is documented. 5.1.2 Orientated or not (suture indicating what
More informationFemale 18. Deeply pigmented lesion on trunk.?warty naevus?seborrhoeic keratosis?malignant melanoma. The best diagnosis is:
Female 18. Deeply pigmented lesion on trunk.?warty naevus?seborrhoeic keratosis?malignant melanoma. The best diagnosis is: A. deep penetrating naevus B. naevoid malignant melanoma C. pigment synthesising
More informationMelanoma Update: 8th Edition of AJCC Staging System
Melanoma Update: 8th Edition of AJCC Staging System Rosalie Elenitsas, M.D. Professor of Dermatology Director, Dermatopathology University of Pennsylvania DISCLOSURE OF RELATIONSHIPS WITH INDUSTRY None
More informationMING H. JIH, MD,PHD, PAUL M. FRIEDMAN, MD,LEONARD H. GOLDBERG, MD,AND ARASH KIMYAI-ASADI, MD. Methods Phase I: Retrospective (Group 1)
Curettage prior to Mohs Micrographic Surgery for Previously Biopsied Nonmelanoma Skin Cancers: What Are We Curetting? Retrospective, Prospective, and Comparative Study MING H. JIH, MD,PHD, PAUL M. FRIEDMAN,
More informationProtocol applies to melanoma of cutaneous surfaces only.
Melanoma of the Skin Protocol applies to melanoma of cutaneous surfaces only. Procedures Biopsy (No Accompanying Checklist) Excision Re-excision Protocol revision date: January 2005 Based on AJCC/UICC
More informationA dinical and histopathologic entity associated with an increased risk of nonmelanoma skin cancer
PUVA keratosis A dinical and histopathologic entity associated with an increased risk of nonmelanoma skin cancer M. C. G. van Praag, MD, a J. N. Bouwes Bavinck, MD, a W. Bergman, MD, PhD, a F. R. Rosendaal,
More informationAssisting diagnosis of melanoma through the noninvasive biopsy of skin lesions
Assisting diagnosis of melanoma through the noninvasive biopsy of skin lesions Symon D Oyly Cotton Ela Claridge School of Computer Science, The University of Birmingham Birmingham B15 2TT, UK Per Hall
More informationRegression 2/3/18. Histologically regression is characterized: melanosis fibrosis combination of both. Distribution: partial or focal!
Regression Margaret Oliviero MSN, ARNP Harold S. Rabinovitz MD Histologically regression is characterized: melanosis fibrosis combination of both Distribution: partial or focal! Dermatoscopic terminology
More information=ﻰﻤاﻤﺤﻠا ﺔﻴﻘﻠﺤﻠا ﺔذﺒاﻨﻠا
1 / 15 Erythema Annulare Centrifugum and Other Figurate Erythemas The figurate erythemas include a variety of eruptions characterized by annular and polycyclic lesions. Classification of this group has
More informationTHERE IS A GROUP OF PAtients. Defining Urticarial Dermatitis. A Subset of Dermal Hypersensitivity Reaction Pattern
STUDY Defining Urticarial Dermatitis A Subset of Dermal Hypersensitivity Reaction Pattern Steven Kossard, FACD; Ian Hamann, FACD; Barbara Wilkinson, BSc Background: Urticarial dermatitis may represent
More informationMaligna Melanoma and Atypical Fibroxanthoma: An Unusual Collision Tumour G Türkcü 1, A Keleş 1, U Alabalık 1, D Uçmak 2, H Büyükbayram 1 ABSTRACT
Maligna Melanoma and Atypical Fibroxanthoma: An Unusual Collision Tumour G Türkcü 1, A Keleş 1, U Alabalık 1, D Uçmak 2, H Büyükbayram 1 ABSTRACT Two different neoplasia in the same biopsy material called
More informationDisclosure. Objectives. PAFP CME Conference Lou Mancano MD, FAAFP Reading Health System November 18, 2016
PAFP CME Conference Lou Mancano MD, FAAFP Reading Health System November 18, 2016 1 Disclosure The speaker has no conflict of interest, financial agreement, or working affiliation with any group or organization.
More informationInteresting Case Series. Aggressive Tumor of the Midface
Interesting Case Series Aggressive Tumor of the Midface Adrian Frunza, MD, Dragos Slavescu, MD, and Ioan Lascar, MD, PhD Bucharest Emergency Clinical Hospital, Bucharest University School of Medicine,
More informationBasics of Skin Biopsy Techniques
Basics of Skin Biopsy Techniques Kelly Quinn, D.O. Lehigh Valley Health Network/PCOM Department of Dermatology Osteopathic Medical Conference and Exposition October 7, 2017 None to disclose Conflicts of
More informationMultiple Primary Melanoma in a Thai Male: A Case Report
Case Report Multiple Primary Melanoma in a Thai Male: A Case Report J Med Assoc Thai 2014; 97 (Suppl. 2): S234-S238 Full text. e-journal: http://www.jmatonline.com Kittisak Payapvipapong MD*, Pinyapat
More informationSkin biopsy in the diagnosis of neoplastic skin disease
FOCUS Skin biopsy in the diagnosis of neoplastic skin disease Nathan Tobias Harvey, Jonathan Chan, Benjamin Andrew Wood Background Biopsy for diagnostic and therapeutic purposes is a central component
More informationDermatology Procedure Coding
Dermatology Procedure Coding Anatomy Two layers that make up human skin Epidermis most superficial layer Composed of four to five layers called stratum Anyone remember the mnemonic? Thickness varies based
More informationF006 Imaging in Dermatology Melanocytic Neoplasia Clinical-Confocal-Pathological-Correlations
F006 Imaging in Dermatology Melanocytic Neoplasia Clinical-Confocal-Pathological-Correlations Melissa Gill, MD SkinMedical Research and Diagnostics Dobbs Ferry, NY, USA Department of Pathology SUNY Downstate
More informationJAM ACAD DERMATOL VOLUME 76, NUMBER 2. Research Letters 351
JAM ACAD DERMATOL Research Letters 351 Standard step sectioning of skin biopsy specimens diagnosed as superficial basal cell carcinoma frequently yields deeper and more aggressive subtypes To the Editor:
More informationPeriocular Malignancies
Periocular Malignancies Andrew Gurwood, O.D., F.A.A.O., Dipl. Marc Myers, O.D., F.A.A.O. Drs. Myers and Gurwood have no financial interests to disclose. Course Description Discussion of the most common
More informationMorphologic Features of Melanocytes, Pigmented Keratinocytes, and Melanophages by In Vivo Confocal Scanning Laser Microscopy
Morphologic Features of Melanocytes, Pigmented Keratinocytes, and Melanophages by In Vivo Confocal Scanning Laser Microscopy Klaus J. Busam, M.D., Carlos Charles, M.D., Grace Lee, M.D., Allan C Halpern,
More informationEruptive Tumors of the Follicular Infundibulum: An Unexpected Diagnosis of Hypopigmented Macules
Dermatol Ther (Heidelb) (2015) 5:207 211 DOI 10.1007/s13555-015-0079-0 CASE REPORT Eruptive Tumors of the Follicular Infundibulum: An Unexpected Diagnosis of Hypopigmented Macules Poonkiat Suchonwanit.
More informationPolypoid Melanoma, A Virulent Variant of the Nodular Growth Pattern
Polypoid Melanoma, A Virulent Variant of the Nodular Growth Pattern ELIZABETH A. MANCI, M.D., CHARLES M. BALCH, M.D..TARIQ M. MURAD, M.D., PH.D., AND SENG/JAW SOONG, PH.D. Manci, Elizabeth A., Balch, Charles
More informationClinical characteristics
Skin Cancer Fernando Vega, MD Seattle Healing Arts Clinical characteristics Precancerous lesions Common skin cancers ACTINIC KERATOSIS Precancerous skin lesions Actinic keratoses Dysplastic melanocytic
More informationMucinoses Diverse group of disorders which have in common deposition of basophilic, finely granular and stringy material in the connective tissues of
Cutaneous Mucinoses Nathan C. Walk, M.D. Mucinoses Diverse group of disorders which have in common deposition of basophilic, finely granular and stringy material in the connective tissues of the dermis.
More informationLearning Objectives. Tanning. The Skin. Classic Features. Sun Reactive Skin Type Classification. Skin Cancers: Preventing, Screening and Treating
Learning Objectives Skin Cancers: Preventing, Screening and Treating Robert A. Baldor, MD, FAAFP Professor, Family Medicine & Community Health University of Massachusetts Medical School Distinguish the
More informationGlenn D. Goldman, MD. Fletcher Allen Health Care. University of Vermont College of Medicine
Glenn D. Goldman, MD Fletcher Allen Health Care University of Vermont College of Medicine Recognize and identify the main types of skin cancer Understand how and why Mohs surgery is utilized for the treatment
More informationManagement of pediatric melanocytic lesions
Open Journal of Clinical & Medical Case Reports Management of pediatric melanocytic lesions Volume 3 (2017) Issue 8 ISSN 2379-1039 Jin Kim, BS; Emmanuel Gabriel MD, PhD; Weiguo Liu MD, PhD; Lin Lin MD,
More informationPapillary Lesions of the breast
Papillary Lesions of the breast Emad Rakha Professor of Breast Pathology The University of Nottingham Papillary lesions of the breast are a heterogeneous group of disease, which are characterised by neoplastic
More informationDysplasia, Mimics and Other Controversies
Dysplasia, Mimics and Other Controversies Mary S. Richardson, MD Dept. of Pathology Medical University of South Carolina Charleston, SC Notice of Faculty Disclosure In accordance with ACGME guidelines,
More informationCutaneous Adnexal Tumors
Cutaneous Adnexal Tumors Lesions with Predominant Follicular Differentiation Special Emphasis on Basal Cell Carcinoma 2014-04-01 Prof. Dr. med. Katharina Glatz Pathologie Cutaneous Adnexal Tumors Hair
More informationالطلاوة = Leukoplakia LEUKOPLAKIA
LEUKOPLAKIA Leukoplakia is a clinical term that refers to a predominantly white lesion of the oral mucosa that cannot be rubbed off or characterized by any other definable lesion or known disease. 130
More informationDr. Brent Doolan, BSc MBBS MPH
Impact of partial biopsies on the need for complete excisional surgery in the management of cutaneous melanomas: A multi-centre review Dr. Brent Doolan, BSc MBBS MPH Peter MacCallum Cancer Centre, Melbourne
More informationSkin biopsy. Sophia Otto SA Pathology
Skin biopsy Sophia Otto SA Pathology RCPA (Royal College of Pathologists of Australasia) The RCPA is the leading organisation representing pathologists in Australasia. Its mission is to train and support
More informationFor additional information on meeting the criteria for Mohs, see Appendix 2.
Position Statement on Appropriate Uses of Paraffin Sections in Association (Approved by the Board of Directors: August 1, 2011; Revised November 5, 2011; Revised August 9, 2014) According to AMA/CPT, Mohs
More informationLUMPS AND BUMPS: AN ORGANIZED APPROACH TO DIAGNOSIS AND MANAGEMENT
LUMPS AND BUMPS: AN ORGANIZED APPROACH TO DIAGNOSIS AND MANAGEMENT Tammy P. Than, M.S., O.D., F.A.A.O. The University of Alabama at Birmingham / School of Optometry 1716 University Blvd. Birmingham, AL
More informationSpitz nevi in the classic histopathological pattern - lamb in wolf`s clothing *
DERMATOPATHOLOGY 91 Spitz nevi in the classic histopathological pattern - lamb in wolf`s clothing * Gustavo Costa Verardino 1 Mayra Carrijo Rochael 1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20153310
More informationPigmented skin lesions: are they all of melanocytic origin? A histopathological perspective
Original Article Pigmented skin lesions: are they all of melanocytic origin? A histopathological perspective Rajesh Singh Laishram, Barida Ginia Myrthong, Sharmila Laishram, Rachel Shimray, Arun Kumar
More informationLid Lesions: Relax or Refer
Lid Lesions: Relax or Refer Blair Lonsberry, MS, OD, MEd., FAAO Professor of Optometry Pacific University College of Optometry blonsberry@pacificu.edu Agenda Benign vs. Malignant lesions Benign Eyelid
More informationMorphologic characteristics of nevi associated with melanoma: a clinical, dermatoscopic and histopathologic analysis
DERMATOLOGY PRACTICAL & CONCEPTUAL www.derm101.com Morphologic characteristics of nevi associated with melanoma: a clinical, dermatoscopic and histopathologic analysis Temeida Alendar 1, Harald Kittler
More informationDermoscopy. Sir William Osler. Dermoscopy. Dermoscopy. Melanoma USA Primary Care Update Faculty Disclosure Statement
Diagnostic Ability: Pigmented Lesions Ted Rosen, MD Baylor College of Medicine Houston, Texas Enhanced 2010 Primary Care Update Faculty Disclosure Statement Ted Rosen, MD Speakers Bureau: Abbott, Amgen,
More informationI have a skin lump doc! What s next? 12 th August 2017 Dr. Sue-Ann Ho Ju Ee
I have a skin lump doc! What s next? 12 th August 2017 Dr. Sue-Ann Ho Ju Ee Some thoughts Is this skin cancer? How common is this? How likely is this in this patient? What happens next if it s something
More informationPathology. Skin Tumor. Bayan N. Mohammad 15/10/2015. Mohammad al-orjani. Page 0 of 23
#7 35 Pathology Skin Tumor Bayan N. Mohammad 15/10/2015 Mohammad al-orjani Page 0 of 23 بسم هللا الرحمن الرحيم GREETINGS This lecture is about skin tumors, all the slides are included and every slide will
More informationDermoscopy. Enhanced Diagnostic Ability: Pigmented Lesions. Ted Rosen, MD Baylor College of Medicine Houston, Texas
Dermoscopy Enhanced Diagnostic Ability: Pigmented Lesions Ted Rosen, MD Baylor College of Medicine Houston, Texas Faculty Disclosure Statement No conflicts relevant to this workshop! Sir William Osler
More informationSKIN CANCER. Most common cancer diagnosis 40% of all cancers
SKIN CANCER Most common cancer diagnosis 40% of all cancers OBJECTIVES Review common and uncommon cancers of the skin. Special emphasis on melanoma and dysplastic nevus Review pathology/tnm/staging, which
More informationAbrupt Intralesional Color Change on Dermoscopy as a New Indicator of Early Superficial Spreading Melanoma in a Japanese Woman
Published online: June 24, 2015 1662 6567/15/0072 0123$39.50/0 This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC)
More informationPigmented Seborrheic Keratosis (Melanoacanthoma) of Nipple A case report with review of literature
Case Report Pigmented Seborrheic Keratosis (Melanoacanthoma) of Nipple A case report with review of literature Aparna Narasimha, Harendra Kumar ML, Divyarani MN, Bhaskaran A* Department of Pathology and
More information6/17/2018. Breaking Bad (Part 1) Dermoscopy of Brown(ish) Things. Bad?
Breaking Bad (Part 1) Dermoscopy of Brown(ish) Things Jennie T. Clarke, MD ssociate Professor of Dermatology University of Utah School of Medicine Bad? 1 Brown(ish) Things Bad Melanoma Pigmented basal
More information22/04/2015. Dermoscopy of Melanoma. Ilsphi Browne. Overview
Dermoscopy of Melanoma Ilsphi Browne Overview The device Dermoscopic criteria (terminology) Colour Patterns Global features Local features Approach to diagnosing pigmented lesions Other uses in general
More information